Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Therapy”

3,951 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,951 results

Testing effectiveness (Phase 2)UnknownNCT03848611
What this trial is testing

CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).

Who this might be right for
Non-small Cell Lung Cancer
AnewPharma 20
Large-scale testing (Phase 3)Looking for participantsNCT06752811
What this trial is testing

Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Metastatic
Shanghai Yizhong Pharmaceutical Co., Ltd. 416
Testing effectiveness (Phase 2)Study completedNCT00684099
What this trial is testing

Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890585
What this trial is testing

Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL

Who this might be right for
BTK InhibitorsHistone Deacetylase InhibitorDouble Express Diffuse Large B-cell Lymphoma
Li Zhiming 128
Not applicableLooking for participantsNCT06188585
What this trial is testing

Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding

Who this might be right for
Acute Gastrointestinal Bleeding
Medtronic - MITG 278
Testing effectiveness (Phase 2)Ended earlyNCT00417885
What this trial is testing

A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 6
Early research (Phase 1)Ended earlyNCT01534949
What this trial is testing

Provide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the Pivotal CT-P10 Therapeutic Equivalence Trial

Who this might be right for
Diffuse Large B-Cell Lymphoma
Celltrion 1
Post-approval studies (Phase 4)Study completedNCT02483715
What this trial is testing

Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection

Who this might be right for
Helicobacter Pylori Infection
National Taiwan University Hospital 589
Large-scale testing (Phase 3)Study completedNCT03511963
What this trial is testing

A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRC

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Shanghai Henlius Biotech 677
Testing effectiveness (Phase 2)UnknownNCT01196455
What this trial is testing

Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer

Who this might be right for
Breast CancerMetastasis
Croatian Cooperative Group for Clinical Research in Oncology 39
Post-approval studies (Phase 4)Study completedNCT02959255
What this trial is testing

10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection

Who this might be right for
Helicobacter Pylori Infection
Elpen Pharmaceutical Co. Inc. 364
Not applicableNot Yet RecruitingNCT05990985
What this trial is testing

The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.

Who this might be right for
Diffuse Large B-cell Lymphoma
The First Hospital of Jilin University 20
Post-approval studies (Phase 4)Study completedNCT01498887
What this trial is testing

Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying Therapy

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 347
Testing effectiveness (Phase 2)WithdrawnNCT00678626
What this trial is testing

Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer

Who this might be right for
Breast Cancer
Pfizer
Testing effectiveness (Phase 2)WithdrawnNCT00951444
What this trial is testing

Gemcitabine Hydrochloride and Carboplatin With or Without MK-0646 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Ended earlyNCT03382899
What this trial is testing

Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 101
Testing effectiveness (Phase 2)Active Not RecruitingNCT03816163
What this trial is testing

Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer

Who this might be right for
Pancreatic CancerMetastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 393
Large-scale testing (Phase 3)UnknownNCT04509635
What this trial is testing

Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis

Who this might be right for
Colorectal CancerLiver MetastasesCetuximab
Fudan University 50
Testing effectiveness (Phase 2)UnknownNCT04943653
What this trial is testing

Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Stomach NeoplasmsPaclitaxelPeritoneal Metastases
Seoul St. Mary's Hospital 61
Testing effectiveness (Phase 2)Looking for participantsNCT07176312
What this trial is testing

Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients

Who this might be right for
Gastroesophageal AdenocarcinomaFirst Line TherapyHER2 + Gastric Cancer+2 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 80
Load More Results